Press release
Cervical Cancer Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Orano Med LLC, Hookipa Biotech GmbH, Gilead Sciences, MacroGenics, Genentech, Inc., Precision Biologics, Inc, Agenus Inc., Hoffman
To Know in detail about the Cervical Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Cervical Cancer Market Forecast
https://www.delveinsight.com/sample-request/cervical-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Cervical Cancer Market Report:
• The Cervical Cancer market size was valued ~USD 930 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
• The United States accounted for the highest Cervical Cancer market size valued ~USD 530 million in 2023
• The total incident cases of cervical cancer in the 7MM comprised 40,600 in 2023 and are projected to decrease during the forecast period.
• The US contributed to the largest incident population of cervical cancer, accounting for nearly 34% of the 7MM in 2023.
• Among the total cervical cancer cases by histology, the cases of squamous carcinoma comprised nearly 9,000 cases in 2023 in the US.
• Among the stage-specific cases of cervical cancer, Stage IB comprised the highest number of cases, followed by IVB in the US in 2023.
• Among EU4 and the UK, Germany accounted for the highest number of cervical cancer cases, followed by the UK, whereas Spain accounted for the lowest cases in 2023.
• Key Cervical Cancer Companies: Orano Med LLC, Hookipa Biotech GmbH, Gilead Sciences, MacroGenics, Genentech, Inc., Precision Biologics, Inc, Agenus Inc., Hoffmann-La Roche, Nurix Therapeutics, Inc., Iovance Biotherapeutics, Inc., Sensei Biotherapeutics, Inc., AstraZeneca, Daiichi Sankyo Co., Ltd., Verastem, Inc., CRISPR Therapeutics, Advenchen Laboratories, LLC, and others
• Key Cervical Cancer Therapies: ²¹²Pb-DOTAMGRPR1, HB-201 IT, Sacituzumab govitecan, MGD019, Atezolizumab, NEO-201 in combination with pembrolizumab, AGEN2034, Tiragolumab + Atezolizumab, De-TIL-0255, LN-145 + pembrolizumab, SNS-101 (anti-VISTA), Trastuzumab deruxtecan, Avutometinib (VS-6766) + defactinib, CTX131, AL3818, and others
• The Cervical Cancer market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Cervical Cancer pipeline products will significantly revolutionize the Cervical Cancer market dynamics.
Cervical Cancer Overview
The cells of the cervix, which is the lowest portion of the uterus that links to the vagina, are where cervical cancer develops. It typically starts in the transformation zone of the cervix, spreads to the regional lymph nodes, and frequently invades the parametrium.
Get a Free sample for the Cervical Cancer Market Report:
https://www.delveinsight.com/report-store/cervical-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Cervical Cancer Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Cervical Cancer Epidemiology Segmentation:
The Cervical Cancer market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Cervical Cancer
• Prevalent Cases of Cervical Cancer by severity
• Gender-specific Prevalence of Cervical Cancer
• Diagnosed Cases of Episodic and Chronic Cervical Cancer
Download the report to understand which factors are driving Cervical Cancer epidemiology trends @ Cervical Cancer Epidemiology Forecast
https://www.delveinsight.com/sample-request/cervical-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Cervical Cancer Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cervical Cancer market or expected to get launched during the study period. The analysis covers Cervical Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Cervical Cancer Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Cervical Cancer Therapies and Key Companies
• ²¹²Pb-DOTAMGRPR1: Orano Med LLC
• HB-201 IT: Hookipa Biotech GmbH
• Sacituzumab govitecan: Gilead Sciences
• MGD019: MacroGenics
• Atezolizumab: Genentech, Inc.
• NEO-201 in combination with pembrolizumab: Precision Biologics, Inc
• AGEN2034: Agenus Inc.
• Tiragolumab + Atezolizumab: Hoffmann-La Roche
• De-TIL-0255: Nurix Therapeutics, Inc.
• LN-145 + pembrolizumab: Iovance Biotherapeutics, Inc.
• SNS-101 (anti-VISTA): Sensei Biotherapeutics, Inc.
• Trastuzumab deruxtecan: AstraZeneca/Daiichi Sankyo Co., Ltd.
• Avutometinib (VS-6766) + defactinib: Verastem, Inc.
• CTX131: CRISPR Therapeutics
• AL3818: Advenchen Laboratories, LLC
Discover more about therapies set to grab major Cervical Cancer market share @ Cervical Cancer Treatment Market
https://www.delveinsight.com/sample-request/cervical-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Scope of the Cervical Cancer Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Cervical Cancer Companies: Orano Med LLC, Hookipa Biotech GmbH, Gilead Sciences, MacroGenics, Genentech, Inc., Precision Biologics, Inc, Agenus Inc., Hoffmann-La Roche, Nurix Therapeutics, Inc., Iovance Biotherapeutics, Inc., Sensei Biotherapeutics, Inc., AstraZeneca, Daiichi Sankyo Co., Ltd., Verastem, Inc., CRISPR Therapeutics, Advenchen Laboratories, LLC, and others
• Key Cervical Cancer Therapies: ²¹²Pb-DOTAMGRPR1, HB-201 IT, Sacituzumab govitecan, MGD019, Atezolizumab, NEO-201 in combination with pembrolizumab, AGEN2034, Tiragolumab + Atezolizumab, De-TIL-0255, LN-145 + pembrolizumab, SNS-101 (anti-VISTA), Trastuzumab deruxtecan, Avutometinib (VS-6766) + defactinib, CTX131, AL3818, and others
• Cervical Cancer Therapeutic Assessment: Cervical Cancer current marketed and Cervical Cancer emerging therapies
• Cervical Cancer Market Dynamics: Cervical Cancer market drivers and Cervical Cancer market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Cervical Cancer Unmet Needs, KOL's views, Analyst's views, Cervical Cancer Market Access and Reimbursement
To know more about Cervical Cancer companies working in the treatment market, visit @ Cervical Cancer Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/cervical-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Cervical Cancer Market Report Introduction
2. Executive Summary for Cervical Cancer
3. SWOT analysis of Cervical Cancer
4. Cervical Cancer Patient Share (%) Overview at a Glance
5. Cervical Cancer Market Overview at a Glance
6. Cervical Cancer Disease Background and Overview
7. Cervical Cancer Epidemiology and Patient Population
8. Country-Specific Patient Population of Cervical Cancer
9. Cervical Cancer Current Treatment and Medical Practices
10. Cervical Cancer Unmet Needs
11. Cervical Cancer Emerging Therapies
12. Cervical Cancer Market Outlook
13. Country-Wise Cervical Cancer Market Analysis (2020-2034)
14. Cervical Cancer Market Access and Reimbursement of Therapies
15. Cervical Cancer Market Drivers
16. Cervical Cancer Market Barriers
17. Cervical Cancer Appendix
18. Cervical Cancer Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Latest Reports by DelveInsight
Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market
DelveInsight's "Crows Feet Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Crows Feet, historical and forecasted epidemiology as well as the Crows Feet market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Dermatitis Seborrheic Market https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-market
DelveInsight's "Seborrhoeic Dermatitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Seborrhoeic Dermatitis, historical and forecasted epidemiology as well as the Seborrhoeic Dermatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Gastro Intestinal Bleeding Market https://www.delveinsight.com/report-store/gastro-intestinal-bleeding-market
DelveInsight's "Gastro Intestinal Bleeding Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gastro Intestinal Bleeding, historical and forecasted epidemiology as well as the Gastro Intestinal Bleeding market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Listeriosis Market
https://www.delveinsight.com/report-store/listeriosis-market
DelveInsight's comprehensive report titled "Listeriosis Market Insights, Epidemiology, and Market Forecast - 2034" offers a detailed analysis of Listeriosis. The report presents historical and projected epidemiological data covering incident cases of listeriosis, age-specific cases of listeriosis, gender-specific cases of listeriosis, risk-associated cases of listeriosis, and treated cases of listeriosis.
Point Of Care Glucose Testing Market https://www.delveinsight.com/report-store/point-of-care-glucose-testing-market
DelveInsight's 'Point of Care Glucose Testing Market Insight, Competitive Landscape and Market Forecast, 2030' report delivers an in-depth understanding of Point of Care Glucose Testing and the historical and forecasted Point of Care Glucose Testing market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Substance Drug Abuse Market https://www.delveinsight.com/report-store/substance-drug-abuse-market
DelveInsight's "Substance (Drug) Abuse Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Substance (Drug) Abuse, historical and forecasted epidemiology as well as the Substance (Drug) Abuse market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cervical Cancer Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Orano Med LLC, Hookipa Biotech GmbH, Gilead Sciences, MacroGenics, Genentech, Inc., Precision Biologics, Inc, Agenus Inc., Hoffman here
News-ID: 3542055 • Views: …
More Releases from DelveInsight Business Research
Vitiligo Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA App …
The "Vitiligo Pipeline Insight, 2025" report by DelveInsight delivers an in-depth view of the current clinical development scenario along with the future growth trajectory of the Vitiligo Market.
As per DelveInsight's evaluation, the global Vitiligo treatment pipeline features 20+ leading companies actively engaged in developing 20+ therapeutic candidates. The analysis covers Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and developmental updates.
The Vitiligo Pipeline report offers extensive commercial and clinical…
Myelodysplastic Syndrome Competitive Landscape 2025: Clinical Trial Analysis, Th …
DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight 2025" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Myelodysplastic Syndrome Pipeline Report
• DelveInsight's Myelodysplastic Syndrome…
Fibromyalgia Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA …
According to DelveInsight, the global Fibromyalgia pipeline features more than eight key companies actively developing over ten treatment candidates. The analysis encompasses ongoing clinical trials, therapeutic mechanisms of action, routes of administration, and recent developments within the Fibromyalgia treatment landscape.
The Fibromyalgia Pipeline 2025 report provides an exhaustive evaluation of pipeline products, ranging from preclinical stages to marketed therapies. It includes comprehensive details on each drug's mechanism of action, clinical trial…
Chronic Wounds Competitive Landscape 2025: Clinical Trial Analysis, Therapies, F …
As per DelveInsight's assessment, globally, Chronic Wounds pipeline constitutes 7+ key companies continuously working towards developing 8+ Chronic Wounds treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Chronic Wounds Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Chronic Wounds Market.
The Chronic Wounds Pipeline report embraces in-depth commercial and clinical assessment…
More Releases for Cervical
Increasing Cervical And Back Pain Prevalence Drives Demand For Cervical Pillows: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Cervical Pillows Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market size for cervical pillows has been experiencing consistent growth. The market is projected to expand from a value of $4.17 billion in 2024 to $4.37 billion in 2025, exhibiting a compound annual growth…
Increasing Cervical And Back Pain Prevalence Drives Demand For Cervical Pillows: …
"What market dynamics are playing a key role in accelerating the growth of the cervical pillows market?
The surge in incidence of cervical and back pain is predicted to boost the growth of the cervical pillows market. Such pains often afflict the neck and upper spine, resulting in discomfort and disturbed sleep. The increasing occurrence of these problems is linked to elements like a stationary lifestyle, amplified use of electronic gadgets,…
Cervical Cancer Screening Cervical Cancer Screening Market 2024 Global Share, Ke …
Global Cervical Cancer Screening Market 2024 Research report is segmented into several key regions, with production, consumption, revenue (million USD), market share and growth rate of Cervical Cancer Screening Industry in these regions, from 2024 to 2030 (forecast), covering North America, Europe, Asia Pacific, Middle East & Africa, South & Central America.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPBT00002661/?utm_source=OpenPR&utm_medium=10759
Key Players Analysis:
Abbott
Hologic Corporation
Qiagen N.V.
F Hoffmann-La Roche
Quest Diagnostics
BD
OncoHealth Corp.
Femasys, Inc.
TruScreen
Onko Solutions
The report covers key…
India Cervical Cancer Screening Market India Cervical Cancer Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Overview of the Cervical Cancer
1.1 Introduction
1.2 Stages of the Cervical Cancer
1.2.1 Stage 0
1.2.2 Stage 1
1.2.3 Stage 2
1.2.4 Stage 3
1.2.5 Stage 4
Occurrence Rate of the Cervical Cancer
2.1 Incidence of the Cervical Cancer in Indian States
…
Global Cervical Cancer Diagnostic Testing Devices Market 2017, Global Cervical C …
Focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer
Global Bronchoscopic Devices Market 2017, presents a professional and in-depth study on the current state of the Bronchoscopic Devices market globally, providing basic overview of Bronchoscopic Devices market including definitions, classifications, applications and industry chain structure, Bronchoscopic Devices Market report provides development policies and plans are discussed as well as manufacturing processes and cost…
North America Cervical Dysplasia Market grows with rising awareness about cervic …
Global Cervical Dysplasia Market: Snapshot
Cervical dysplasia is one of the fastest growing market in the field of cancer diagnosis and treatment. Cervical cancer is a precancerous stage and it can be completely cured by early detection. Rising consumer awareness in this regard has led to an increased demand for cervical screenings in the past few years. Government bodies in several developed countries conduct screening programs in order to improve…
